Morphine-nicotine interaction in conditioned place preference in mice after chronic nicotine exposure

Eur J Pharmacol. 2008 Jun 10;587(1-3):169-74. doi: 10.1016/j.ejphar.2008.03.028. Epub 2008 Apr 1.

Abstract

Previously we found that morphine's effects on locomotor activity and brain dopamine metabolism were enhanced in mice after cessation of 7-week oral nicotine treatment. In the present experiments we show that such chronic nicotine exposure cross-sensitizes NMRI mice to the reinforcing effect of morphine in the conditioned place preference paradigm. The nicotine-treated mice developed conditioned place preference after being conditioned twice with morphine 5 mg/kg s.c. whereas in control mice a higher dose (10 mg/kg) of morphine was required. Since the reinforcing effect of morphine is mediated via micro-opioid receptors we used [3H]DAMGO autoradiography to study whether the number (B(max)) or affinity (K(D)) of mu-opioid receptors in the mouse brain are affected following chronic nicotine exposure. However, no changes were found in the number or affinity of micro-opioid receptors in any of the brain areas studied. Neither did we find alterations in the functional activity of mu-opioid receptors studied by [35S]GTPgammaS-binding. In conclusion, chronic oral nicotine treatment augments the reinforcing effects of morphine in mice, and this cross-sensitization does not seem to be mediated by micro-opioid receptors.

MeSH terms

  • Analgesics, Opioid / pharmacology*
  • Animals
  • Autoradiography
  • Conditioning, Operant / drug effects*
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / pharmacology
  • Guanosine 5'-O-(3-Thiotriphosphate) / pharmacology
  • Male
  • Mice
  • Morphine / pharmacology*
  • Naltrexone / pharmacology
  • Narcotic Antagonists / pharmacology
  • Nicotine / pharmacology*
  • Nicotinic Agonists / pharmacology*
  • Receptors, Opioid, mu / drug effects

Substances

  • Analgesics, Opioid
  • Narcotic Antagonists
  • Nicotinic Agonists
  • Receptors, Opioid, mu
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • Naltrexone
  • Nicotine
  • Morphine